Exact Mass: 705.4124

Exact Mass Matches: 705.4124

Found 228 metabolites which its exact mass value is equals to given mass value 705.4124, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fumonisin B2

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-16,18-dihydroxy-5,9-dimethylicosan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


Fumonisin B2 is from Fusarium moniliforme Fumonisin B2 is a fumonisin mycotoxin produced by the fungi Fusarium verticillioides and Fusarium moniliforme. It is a structural analog of fumonisin B1. Fumonisin B2 is more cytotoxic than fumonisin B1. Fumonisin B2 inhibits sphingosine acyltransferase D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens From Fusarium moniliforme

   

Fumonisin B3

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylicosan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins Fumonisin B3 is from Fusarium moniliforme. D009676 - Noxae > D002273 - Carcinogens From Fusarium moniliforme

   

beta1-Chaconine

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-({10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracos-4-en-7-yl}oxy)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H63NO10 (705.4452)


beta1-Chaconine is found in alcoholic beverages. beta1-Chaconine is an alkaloid from potato species (Solanum chacoense, Solanum commersonii, Solanum crispum, Solanum tuberosum, Solanum ajanhuiri and Solanum stenotomum, Solanaceae Alkaloid from potato subspecies (Solanum chacoense, Solanum commersonii, Solanum crispum, Solanum tuberosum, Solanum ajanhuiri and Solanum stenotomum, Solanaceae). beta1-Chaconine is found in alcoholic beverages and potato.

   

Spirolide C

5-[(10E)-9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl]-3-methyl-2,5-dihydrofuran-2-one

C43H63NO7 (705.4604)


Spirolide C is found in crustaceans. Spirolide C is isolated from contaminated shellfish. Isolated from contaminated shellfish. Spirolide C is found in crustaceans and mollusks.

   

PS(14:0/16:1(9Z))

(2S)-2-amino-3-({[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(tetradecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C36H68NO10P (705.4581)


PS(14:0/16:1(9Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(14:0/16:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(14:0/16:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(14:0/16:1(9Z)), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one 9Z-hexadecenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(14:1(9Z)/16:0)

(2S)-2-amino-3-({[(2R)-2-(hexadecanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C36H68NO10P (705.4581)


PS(14:1(9Z)/16:0) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(14:1(9Z)/16:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(14:1(9Z)/16:0) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(14:1(9Z)/16:0), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(16:0/14:1(9Z))

(2S)-2-amino-3-({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C36H68NO10P (705.4581)


PS(16:0/14:1(9Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(16:0/14:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the myristoleic acid moiety is derived from milk fats. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(16:0/14:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(16:0/14:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-tetradecenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(16:1(9Z)/14:0)

(2S)-2-amino-3-({[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(tetradecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C36H68NO10P (705.4581)


PS(16:1(9Z)/14:0) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(16:1(9Z)/14:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the myristic acid moiety is derived from nutmeg and butter. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(16:1(9Z)/14:0) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(16:1(9Z)/14:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one tetradecanoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

norerythromycin

(3R,4R,5S,6S,7S,9S,11R,12S,13R,14S)-6-{[(2R,3S,4R,6S)-4-amino-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

C35H63NO13 (705.4299)


norerythromycin is a metabolite of erythromycin. Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including Mycoplasma and legionellosis. It was first marketed by Eli Lilly and Company, and it is today commonly known as EES (erythromycin ethylsuccinate, an ester prodrug that is commonly administered). (Wikipedia)

   

D-Glucoside

9-[2-[Methoxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]acetyl]oxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H63NO10 (705.4452)


   

gamma-Secretase Inhibitor II

4-({2-[(2-{[(tert-butoxy)(hydroxy)methylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxy-3-methylpentylidene}amino)-2,2-difluoro-N-{1-[(1-methoxy-3-methyl-1-oxopentan-2-yl)-C-hydroxycarbonimidoyl]-2-methylpropyl}-3-oxopentanimidate

C33H57F2N5O9 (705.4124)


   

beta-2-Chaconine

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-({10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracos-4-en-7-yl}oxy)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H63NO10 (705.4452)


Beta-2-chaconine is a member of the class of compounds known as steroidal saponins. Steroidal saponins are saponins in which the aglycone moiety is a steroid. The steroidal aglycone is usually a spirostane, furostane, spirosolane, solanidane, or curcubitacin derivative. Beta-2-chaconine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Beta-2-chaconine can be found in potato, which makes beta-2-chaconine a potential biomarker for the consumption of this food product.

   
   

beta-Chaconine

solanid-5-en-3beta-yl 3-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside

C39H63NO10 (705.4452)


   

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

NCGC00380841-01!2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


   

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

NCGC00347714-02!(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


   

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


   

fumonisin B2

1,1-[(1S,2R)-1-[(2S,9R,11S,12S)-12-amino-9,11-dihydroxy-2-methyltridecyl]-2-[(1R)-1-methylpentyl]-1,2-ethanediyl]ester-1,2,3-propanetricarboxylic acid

C34H59NO14 (705.3935)


A fumonisin that is (2S,3S,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,14,15-triol in which the hydroxy groups at positions 14 and 15 have each been esterified by condensation with the 1-carboxy group of 3-carboxyglutaric acid (giving a 3-carboxyglutarate ester group with R configuration in each case). D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens CONFIDENCE standard compound; INTERNAL_ID 5969 CONFIDENCE Reference Standard (Level 1)

   

Fumonisin B3

2-[2-[(5R,6R,7S,9S,11R,18S,19R)-19-amino-6-(3,4-dicarboxybutanoyloxy)-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens CONFIDENCE isolated standard

   

Solanidine base + O-Hex-dHex

Solanidine base + O-Hex-dHex

C39H63NO10 (705.4452)


Annotation level-3

   

PS(13:0/17:1(9Z))

1-tridecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(14:1(9Z)/16:0)

1-(9Z-tetradecenoyl)-2-hexadecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(15:0/15:1(9Z))

1-pentadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(15:1(9Z)/15:0)

1-(9Z-pentadecenoyl)-2-pentadecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(16:0/14:1(9Z))

1-hexadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(16:1(9Z)/14:0)

1-(9Z-hexadecenoyl)-2-tetradecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(17:1(9Z)/13:0)

1-(9Z-heptadecenoyl)-2-tridecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(18:1(9Z)/12:0)

1-(9Z-octadecenoyl)-2-dodecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(14:0/16:1(9Z))

1-tetradecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PS(12:0/18:1(9Z))

1-dodecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

b1-Chaconine

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-({10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0^{2,11}.0^{5,10}.0^{15,23}.0^{17,22}]tetracos-4-en-7-yl}oxy)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H63NO10 (705.4452)


   

Spirolide C

5-{9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1^{1,4}.1^{4,7}.0^{12,17}.0^{17,23}]pentatriaconta-10,13,22-trien-14-yl}-3-methyl-2,5-dihydrofuran-2-one

C43H63NO7 (705.4604)


   

PS 30:1

1-(9Z-pentadecenoyl)-2-pentadecanoyl-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

PHODA-PC

1-hexadecanoyl-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phosphocholine

C36H68NO10P (705.4581)


   

OHDdiA-PE

1-(9Z-octadecenoyl)-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phosphoethanolamine

C35H64NO11P (705.4217)


   

PKODA-PS

1-hexadecanoyl-2-(9,12-dioxo-10E-dodecenoyl)-sn-glycero-3-phosphoserine

C34H60NO12P (705.3853)


   

CID 101136678

CID 101136678

C43H63NO7 (705.4604)


   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

C42H51N5O5 (705.389)


   

(9Z)-17-hydroxyoctadec-9-enoate 17-O-diacetylsophoroside

(9Z)-17-hydroxyoctadec-9-enoate 17-O-diacetylsophoroside

C34H57O15- (705.3697)


   
   
   

Lnape 26:7/N-8:0

Lnape 26:7/N-8:0

C39H64NO8P (705.4369)


   
   
   
   

Lnape 8:0/N-26:7

Lnape 8:0/N-26:7

C39H64NO8P (705.4369)


   
   
   
   
   

SHexCer 14:3;2O/14:1;O

SHexCer 14:3;2O/14:1;O

C34H59NO12S (705.3758)


   

SHexCer 16:3;2O/12:1;O

SHexCer 16:3;2O/12:1;O

C34H59NO12S (705.3758)


   

SHexCer 15:3;2O/13:1;O

SHexCer 15:3;2O/13:1;O

C34H59NO12S (705.3758)


   

Lnaps 13:1/N-17:0

Lnaps 13:1/N-17:0

C36H68NO10P (705.4581)


   

Lnaps 14:1/N-16:0

Lnaps 14:1/N-16:0

C36H68NO10P (705.4581)


   

Lnaps 19:1/N-11:0

Lnaps 19:1/N-11:0

C36H68NO10P (705.4581)


   

Lnaps 17:0/N-13:1

Lnaps 17:0/N-13:1

C36H68NO10P (705.4581)


   

Lnaps 15:1/N-15:0

Lnaps 15:1/N-15:0

C36H68NO10P (705.4581)


   

Lnaps 16:1/N-14:0

Lnaps 16:1/N-14:0

C36H68NO10P (705.4581)


   

Lnape 16:3/N-18:4

Lnape 16:3/N-18:4

C39H64NO8P (705.4369)


   

Lnaps 15:0/N-15:1

Lnaps 15:0/N-15:1

C36H68NO10P (705.4581)


   

Lnaps 17:1/N-13:0

Lnaps 17:1/N-13:0

C36H68NO10P (705.4581)


   

Lnaps 14:0/N-16:1

Lnaps 14:0/N-16:1

C36H68NO10P (705.4581)


   

Lnape 18:4/N-16:3

Lnape 18:4/N-16:3

C39H64NO8P (705.4369)


   

Lnape 10:0/N-24:7

Lnape 10:0/N-24:7

C39H64NO8P (705.4369)


   

Lnaps 13:0/N-17:1

Lnaps 13:0/N-17:1

C36H68NO10P (705.4581)


   

Lnaps 20:1/N-10:0

Lnaps 20:1/N-10:0

C36H68NO10P (705.4581)


   

Lnaps 18:1/N-12:0

Lnaps 18:1/N-12:0

C36H68NO10P (705.4581)


   

Lnape 24:7/N-10:0

Lnape 24:7/N-10:0

C39H64NO8P (705.4369)


   

Lnaps 16:0/N-14:1

Lnaps 16:0/N-14:1

C36H68NO10P (705.4581)


   

Lnaps 12:0/N-18:1

Lnaps 12:0/N-18:1

C36H68NO10P (705.4581)


   

Lnaps 11:0/N-19:1

Lnaps 11:0/N-19:1

C36H68NO10P (705.4581)


   

Lnaps 10:0/N-20:1

Lnaps 10:0/N-20:1

C36H68NO10P (705.4581)


   

PI-Cer 16:3;2O/12:1;O

PI-Cer 16:3;2O/12:1;O

C34H60NO12P (705.3853)


   

PI-Cer 15:3;2O/13:1;O

PI-Cer 15:3;2O/13:1;O

C34H60NO12P (705.3853)


   

PI-Cer 14:3;2O/14:1;O

PI-Cer 14:3;2O/14:1;O

C34H60NO12P (705.3853)


   

2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C38H60NO9P (705.4005)


   
   

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935)


   

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[3-hexanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-hexanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C39H64NO8P (705.4369)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C39H64NO8P (705.4369)


   

2-amino-3-[[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[hydroxy-[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[3-hexadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-hexadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[3-decanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-decanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[3-heptadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-heptadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H64NO8P (705.4369)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C39H64NO8P (705.4369)


   

2-amino-3-[[3-dodecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-dodecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

2-amino-3-[[3-butanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-butanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]octanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]octanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]hexanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyicosa-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyicosa-4,8-dien-2-yl]propanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]pentanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]decanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]decanamide

C35H63NO13 (705.4299)


   

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]tridec-9-enamide

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]tridec-9-enamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]undecanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]undecanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]heptanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]heptanamide

C35H63NO13 (705.4299)


   

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]pentadec-9-enamide

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]pentadec-9-enamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]nonanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]nonanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonadeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonadeca-4,8-dien-2-yl]butanamide

C35H63NO13 (705.4299)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhenicosa-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhenicosa-4,8-dien-2-yl]acetamide

C35H63NO13 (705.4299)


   

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]tetradec-9-enamide

(Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]tetradec-9-enamide

C35H63NO13 (705.4299)


   

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H56NO10P (705.3642)


   

(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-octadec-17-enoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-octadec-17-enoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-octadec-17-enoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-octadec-17-enoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C39H64NO8P (705.4369)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[hydroxy-[(2R)-2-pentadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-2-pentadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-3-[(E)-heptadec-9-enoyl]oxy-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-3-[(E)-heptadec-9-enoyl]oxy-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[hydroxy-[(2R)-3-pentadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-3-pentadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C39H64NO8P (705.4369)


   

(2S)-2-amino-3-[[(2R)-3-hexadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-3-hexadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C39H64NO8P (705.4369)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C39H64NO8P (705.4369)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-2-dodecanoyloxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C39H64NO8P (705.4369)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (10E,12E)-octadeca-10,12-dienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (10E,12E)-octadeca-10,12-dienoate

C39H64NO8P (705.4369)


   

(2S)-2-amino-3-[[(2R)-2-hexadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-2-hexadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-3-dodecanoyloxy-2-[(E)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

(2S)-2-amino-3-[[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H68NO10P (705.4581)


   

1-tetradecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoserine

1-tetradecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

beta1-Chaconine

beta1-Chaconine

C39H63NO10 (705.4452)


   

1-hexadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

1-hexadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

C36H68NO10P (705.4581)


   

norerythromycin

norerythromycin

C35H63NO13 (705.4299)


   

PC(31:7)

PC(20:4_11:3)

C39H64NO8P (705.4369)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

PC O-16:0/12:3;O3

PC O-16:0/12:3;O3

C36H68NO10P (705.4581)


   
   
   

PC P-16:0/12:2;O3

PC P-16:0/12:2;O3

C36H68NO10P (705.4581)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PE O-20:0/11:3;O3

PE O-20:0/11:3;O3

C36H68NO10P (705.4581)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

PS O-16:0/13:3;O2

PS O-16:0/13:3;O2

C35H64NO11P (705.4217)


   
   
   

PS P-16:0/12:3;O3

PS P-16:0/12:3;O3

C34H60NO12P (705.3853)


   

PS P-16:1/12:2;O3

PS P-16:1/12:2;O3

C34H60NO12P (705.3853)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

IPC 12:2;O2/16:2;O

IPC 12:2;O2/16:2;O

C34H60NO12P (705.3853)


   
   
   
   

ST 29:5;O7;HexNAc

ST 29:5;O7;HexNAc

C37H55NO12 (705.3724)


   

(e,2e,4e,9e)-n-[(1e)-2-[({5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl}methyl)-c-hydroxycarbonimidoyl]eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

(e,2e,4e,9e)-n-[(1e)-2-[({5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl}methyl)-c-hydroxycarbonimidoyl]eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

C37H51N7O7 (705.385)


   

(5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl]-3-methyl-5h-furan-2-one

(5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl]-3-methyl-5h-furan-2-one

C43H63NO7 (705.4604)


   

5-[(10z)-9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl]-3-methyl-5h-furan-2-one

5-[(10z)-9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl]-3-methyl-5h-furan-2-one

C43H63NO7 (705.4604)


   

4-({2-[(1,3-dihydroxy-4-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-methylbutylidene}amino)-3-methylbutylidene]amino}-6-methylheptylidene)amino]-1-hydroxypropylidene}amino)-3-hydroxy-5-phenylpentanoic acid

4-({2-[(1,3-dihydroxy-4-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxybutylidene)amino]-3-methylbutylidene}amino)-3-methylbutylidene]amino}-6-methylheptylidene)amino]-1-hydroxypropylidene}amino)-3-hydroxy-5-phenylpentanoic acid

C36H59N5O9 (705.4313)


   

(2r)-2-(2-{[(5s,6s,7s,9r,16s,18s,19s)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

(2r)-2-(2-{[(5s,6s,7s,9r,16s,18s,19s)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

C34H59NO14 (705.3935)


   

5-{9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl}-3-methyl-5h-furan-2-one

5-{9,32-dihydroxy-6,10,13,19,20,32-hexamethyl-27-methylidene-33,34,35-trioxa-22-azahexacyclo[27.3.1.1¹,⁴.1⁴,⁷.0¹²,¹⁷.0¹⁷,²³]pentatriaconta-10,13,22-trien-14-yl}-3-methyl-5h-furan-2-one

C43H63NO7 (705.4604)


   

2-(2-{[(5r,6r,7s,9s,11r,18r,19s)-19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

2-(2-{[(5r,6r,7s,9s,11r,18r,19s)-19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

C34H59NO14 (705.3935)


   

(2r)-2-(2-{[(5r,6r,7s,9s,11r,18s,19r)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

(2r)-2-(2-{[(5r,6r,7s,9s,11r,18s,19r)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

C34H59NO14 (705.3935)


   

(1r,3as,5ar,5br,9s,11ar)-9-[(2-{methoxy[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}acetyl)oxy]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,9s,11ar)-9-[(2-{methoxy[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}acetyl)oxy]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H63NO10 (705.4452)


   

(2r,3r,4r,5r,6s)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(1s,2s,7s,10r,11s,14s,15r,16r,17r,20s,23s)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracos-4-en-7-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(1s,2s,7s,10r,11s,14s,15r,16r,17r,20s,23s)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracos-4-en-7-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H63NO10 (705.4452)


   
   

(e,2e,4e,9e)-n-[(1e)-2-({[(5s)-5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl]methyl}-c-hydroxycarbonimidoyl)eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

(e,2e,4e,9e)-n-[(1e)-2-({[(5s)-5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl]methyl}-c-hydroxycarbonimidoyl)eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

C37H51N7O7 (705.385)


   

(2r)-2-(2-{[(5r,6r,7s,9s,11r,18r,19s)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

(2r)-2-(2-{[(5r,6r,7s,9s,11r,18r,19s)-19-amino-6-{[(3r)-3,4-dicarboxybutanoyl]oxy}-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy}-2-oxoethyl)butanedioic acid

C34H59NO14 (705.3935)